Transforming growth factor alpha (TGFalpha) in hepatocellular carcinomas and adjacent hepatic parenchyma.
We examined stage T1 to T4 hepatocellular carcinomas (HCC) to determine whether transforming growth factor alpha (TGFalpha) presence differed between early- and late-stage HCC and between tumors with low and high proliferative rates. Paraffin sections from 36 HCC were evaluated for TGFalpha and the proliferation markers Kiel 67 antigen (Ki67) or proliferating cell nuclear antigen (PCNA) by immunoperoxidase staining. In 12 cases, double staining for TGFalpha and Ki67 was also performed. Eighty-one percent of tumors and 94% of adjacent liver sections contained TGFalpha. A trend toward inverse correlation was seen between the percentage of TGFalpha-positive tumor cells and the proliferative rate as determined by Ki67 staining. No clear correlation of TGFalpha to either tumor stage or percentage of PCNA-positive cells was seen. This study confirms the presence of TGFalpha in the majority of early- and late-stage HCC. Positivity within tumor tissue is consistent with autocrine or paracrine stimulation. A trend toward inverse correlation between TGFalpha-producing cells and the number of cycling cells suggests that rapidly proliferating tumors may consume this growth factor at an accelerated rate. Alternatively, other hepatic mitogens may have more functional significance in these latter tumors. Finally, the presence of TGFalpha in peritumoral hepatocytes suggests these cells as potential sources of paracrine stimulation for HCC.
Nalesnik
M A
MA
Division of Transplantation Pathology, University of Pittsburgh Medical Center, PA 15213, USA.
Lee
R G
RG
Carr
B I
BI
D001158:Arteries / Q000378:metabolism / Q000473:pathology; D006528:Carcinoma, Hepatocellular / Q000378:metabolism* / Q000473:pathology; D002452:Cell Count; D004727:Endothelium / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D019394:Ki-67 Antigen / Q000378:metabolism; D008099:Liver / Q000378:metabolism* / Q000473:pathology; D008103:Liver Cirrhosis / Q000378:metabolism / Q000473:pathology; D008113:Liver Neoplasms / Q000378:metabolism* / Q000473:pathology; D018809:Proliferating Cell Nuclear Antigen / Q000378:metabolism; D016211:Transforming Growth Factor alpha / Q000378:metabolism*
D019394:Ki-67 Antigen; D018809:Proliferating Cell Nuclear Antigen; D016211:Transforming Growth Factor alpha